Literature DB >> 16060119

Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.

Sandeep Mahajan1, Om P Kalra, K Tripathi Asit, Gaurav Ahuja, Vikram Kalra.   

Abstract

BACKGROUND: Susceptibility to infections is a major cause of high morbidity and mortality in patients with chronic kidney disease (CKD). Polymorphonuclear leukocytes (PMNs) play a major role in the host defense against various infections. Although the phagocytic function of PMNs in uremic patients has been subjected to repeated evaluation, results have been inconsistent. Also, the effects of progressive uremia and acute hemodialysis (HD) on polymorphonuclear function have been scarcely evaluated.
METHODS: In this study, we assessed the phagocytic index (PI) of PMNs following their uptake of IgG-coated sheep erythrocytes in patients with varying severity of CKD and in healthy controls. In patients with advanced renal failure, the effects of acute HD on PI pre- and post-HD were also studied.
RESULTS: A total of 30 patients with CKD and 15 healthy controls were studied. Patients with CKD were categorized into two groups: mild to moderate renal failure (S. Creatinine 2-6 mg/dL) and advanced renal failure (S. Creatinine >6 mg/dL) (n=15 for each). All three groups were age and sex matched. Patients with advanced renal failure had significantly impaired PI (4.03 +/- 1.15) as compared to patients with mild to moderate renal failure (7.17 +/- 2.62) and normal controls (8.13 +/- 3.31) (p < 0.001 for both). There was a statistically insignificant decline in the PI in patients with mild to moderate RF when compared to controls (7.17 +/- 2.62 versus 8.13 +/- 3.31). In patients with advanced renal failure, acute HD led to a significant improvement in PI (5.52 +/- 1.55 versus 4.03 +/- 1.15, p < 0.01).
CONCLUSION: In patients with CKD, there is a progressive decline in the phagocytic index of the PMNs with increasing severity of uremia. Significant improvement in the phagocytic index following acute hemodialysis suggests the role of a circulating uremic toxin in this PMN dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060119

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Functional miR143/145 Cluster Variants and Haplotypes Are Associated with Chronic Kidney Disease: a Preliminary Case-Control Study and Computational Analyses.

Authors:  Saman Sargazi; Milad Heidari Nia; Fariba Mirani Sargazi; Roghayeh Sheervalilou; Ramin Saravani; Sara Bahrami; Shekoufeh Mirinejad; Ali Alidadi
Journal:  Appl Biochem Biotechnol       Date:  2021-01-23       Impact factor: 2.926

2.  Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Authors:  David M Charytan; Eldrin F Lewis; Akshay S Desai; Larry A Weinrauch; Peter Ivanovich; Robert D Toto; Brian Claggett; Jiankang Liu; L Howard Hartley; Peter Finn; Ajay K Singh; Andrew S Levey; Marc A Pfeffer; John J V McMurray; Scott D Solomon
Journal:  Am J Kidney Dis       Date:  2015-04-29       Impact factor: 8.860

3.  Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients.

Authors:  Gerald Cohen; Jana Raupachova; Dalibor Ilic; Johannes Werzowa; Walter H Hörl
Journal:  Nephrol Dial Transplant       Date:  2011-01-07       Impact factor: 5.992

Review 4.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

5.  Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease.

Authors:  Jwa-Kyung Kim; Chang-Won Hong; Mi Jin Park; Young Rim Song; Hyung Jik Kim; Sung Gyun Kim
Journal:  J Immunol Res       Date:  2017-03-27       Impact factor: 4.818

Review 6.  Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells.

Authors:  Maxime Espi; Laetitia Koppe; Denis Fouque; Olivier Thaunat
Journal:  Toxins (Basel)       Date:  2020-05-06       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.